Israeli R&D Team Claim To Be Near COVID-19 Vaccine
MIGAL Researchers Had Already Developed An Avian Coronavirus Vaccine
An Israeli research team has discovered a potential COVID-19 vaccine candidate as a by-product of an avian vaccine they were developing and one of the team’s leaders told Scrip they hope to start producing and testing it by May.
You may also be interested in...
Evotec’s multimodality approach to drug discovery landed the biotech two new discovery collaborations this week, underscoring its emphasis on patient-driven data.
Novo Nordisk and Evotec will identify and develop novel drugs for treating chronic kidney disease, using datasets of CKD patients provided by the Danish group and from other sources.
Sanofi is paying for $3.68bn cash for Principia to get the US biotech’s drug development platform and nascent pipeline, including a brain-penetrant BTK inhibitor in Phase III for multiple sclerosis.